Affiliation:
1. Alissa C. Cyrus, Centers for Disease Control and Prevention, Division of Human Development and Disability; Julie Royer, South Carolina Revenue and Fiscal Affairs Office; Dianna D. Carrol and Elizabeth A. Courtney-Long, Centers for Disease Control and Prevention, Division of Human Development and Disability; Suzanne McDermott, Department of Epidemiology and Biostatistics, Arnold School of Public H
Abstract
Abstract
Adults with intellectual and developmental disabilities (IDD) are known to experience significant health disparities; however, few studies have described anti-hypertensive medication adherence in this population. Using administrative data from South Carolina from 2000–2014, we evaluated the odds of adherence to anti-hypertensive medication among a cohort of adults with IDD and hypertension. Approximately half (49.5%) of the study cohort were adherent to anti-hypertensive medication. Those who lived in a supervised residence, had a Medicaid waiver, and had more frequent contact with a primary care provider were more likely to be adherent. Organizations that serve people with IDD have an opportunity to increase adherence by educating these individuals, their family members, and caregivers about the importance of adherence to anti-hypertensive medication.
Publisher
American Association on Intellectual and Developmental Disabilities (AAIDD)
Subject
Psychiatry and Mental health,Clinical Neurology,Arts and Humanities (miscellaneous),Developmental and Educational Psychology,Neuropsychology and Physiological Psychology,General Medicine,Pediatrics, Perinatology, and Child Health
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献